Results 151 to 160 of about 13,032,569 (265)

Phase Ib Trial of Finotonlimab Combined With SCT200 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Effective treatment options remain limited for patients with recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC), including patients who have progressed after platinum‐based chemotherapy and systemic‐therapy‐naïve patients.
Jinguan Lin, Song Qu, Kunyu Yang, Tao Zhang, Yuansong Bai, Jian Wu, Yanjing Huang, Meiyu Fang, Xianling Liu, Xiaoming Huang, Nianyong Chen, Zhendong Li, Weidong Li, Songnan Zhang, Shurong Zhang, Guangyuan Hu, Yan Sun, Xiaohong Chen, Yanyan Liu, Shanghua Jing, Liangfang Shen, Zhiwei Chang, Liangzhi Xie, Wenlin Gai, Yan Wang, Xinyue Chen, Dongfang Liu, Ye Guo   +27 more
wiley   +1 more source

Real‐World Efficacy and Systemic Immune Modulation Upon Tralokinumab Treatment in Atopic Dermatitis

Clinical and Translational Allergy, Volume 16, Issue 9, September 2026.
ABSTRACT Background Tralokinumab, an interleukin‐13 (IL‐13) monoclonal antibody, has shown clinical efficacy in randomized trials for moderate‐to‐severe atopic dermatitis (AD). This study aims to evaluate clinical and immunological outcome upon tralokinumab treatment in a real‐world cohort of patients with moderate‐to‐severe AD. Methods We recruited 81
Meslina Almaci, Philipp Globig, Davender Redhu, Margitta Worm   +3 more
wiley   +1 more source

Cardiovascular Immune‐Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review and Meta‐Summary of Case Reports

Cancer Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background Reports of immune checkpoint inhibitor (ICI) therapy‐associated immune‐related adverse events (irAEs) exhibit considerable heterogeneity, particularly when comparing data from clinical trials and real‐world observational studies. Methods We conducted a systematic review of real‐world observational studies (case reports and series ...
Shea‐Lee Godin, Tyler Kingma, Ashwin Pillai, Obada Kholoki, Agnes S. Kim   +4 more
wiley   +1 more source

A case of Dupilumab monotherapy in a patient with IgG4-related disease

JAAD Case Reports
Yan Chen, MD, Jiahui Zhao, PhD, MD, Lingling Liu, MD   +2 more
doaj   +1 more source

Markedly Enhancing Adrenal Pseudotumor: IgG4-Related Disease. [PDF]

Int J Rheum Dis
Liu X, Sun Y, Liao W.
europepmc   +1 more source

B‐Cell Remodeling and Regulatory Phenotypes During Acute COVID‐19 Are Unaffected by Polyclonal Anti‐SARS‐CoV‐2 Antibody XAV‐19

European Journal of Immunology, Volume 56, Issue 9, September 2026.
SARS‐CoV‐2 infection drives transient B‐cell remodeling toward an activated, regulatory‐like phenotype. In this randomized sub‐study, the polyclonal neutralizing antibody XAV‐19 did not detectably alter B‐cell phenotype, transcriptome, or function relative to placebo, indicating that passive polyclonal therapy preserves B‐cell homeostasis during acute ...
Nicolas Degauque, Richard Danger, Hoa Le Mai, Marion Cadoux, Thi‐Van‐Ha Nguyen, Gaëlle Tilly, François Raffi, Thomas Guimard, Karine Lacombe, Didier Laureillard, Laurent Hocqueloux, Vincent Dubee, Florence Ader, Cynthia Fourgeux, Jérémie Poschmann, Bernard Vanhove, Odile Duvaux, Benjamin Gaborit, Sophie Brouard, POLYCOR study group   +19 more
wiley   +1 more source

Clinical Images: Features of IgG4-related disease in a patient with granulomatosis with polyangiitis. [PDF]

ACR Open Rheumatol
Kollert F, Bisharat DR, Widmer V, Hausenberger B, Negoias S, Heijnen I, Tzankov A, Mertz K, Kyburz D, Daikeler T.   +9 more
europepmc   +1 more source

Identification of Discriminatory Factors and Construction of a Nomogram for Differentiating IgG4‐RD and DLBCL

Immunity, Inflammation and Disease, Volume 14, Issue 9, September 2026.
ABSTRACT Objective To determine clinically useful indicators that distinguish IgG4‐related disease (IgG4‐RD) from diffuse large B‐cell lymphoma (DLBCL) and to construct a predictive model that may assist early identification. Methods We retrospectively analyzed 19 patients with IgG4‐RD and 37 with DLBCL who presented with lymphadenopathy and received ...
Yongkang Chen, Weimiao Li, Zhou Zhou, Jiqing Wu, Dongmei Zhou   +4 more
wiley   +1 more source

Transcriptomic associations and biomarkers in ANCA‑associated Glomerulonephritis and IgG4‑related Disease: A bioinformatics and machine learning study. [PDF]

PLoS One
Li X, Qiao Y.
europepmc   +1 more source

Pediatric orbital IgG4-related disease: A case series. [PDF]

Am J Ophthalmol Case Rep
Asadigandomani H, Malekpour A, Rajabi MT, Aghajani A, Asadi Amoli F, Rafizadeh SM.   +5 more
europepmc   +1 more source